Skip to content
value.today

Ekso Bionics, Inc.

Formerly Berkeley Exotech, Inc., Berkeley Bionics, Inc.

Total raised
$14 M
2 rounds on record
Latest round
$5 M
Oct 2013
First round on record
Dec 2011
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Ekso Bionics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2013$5 MNo. 2$2 to $10 million

Ekso Bionics, Inc.: Raise no. 2, Oct 2013

Investors in this round

34 investors had bought by the notice of Nov 27, 2013: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: 10% Secured Convertible Promissory Notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$500,000
Finders' fees
none
Paid to its own people
$80,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frank Moremand · Executive Officer · Chief Operating Officer
  • Max Scheder-Bieschin · Executive Officer · Chief Financial Officer
  • Nathan Harding · Executive Officer, Director · Chief Executive Officer
  • Russ Angold · Executive Officer, Promoter · Chief Technology Officer
  • Amal Moorad · Director, Promoter
  • Jack Peurach · Director
  • Marilyn Hamilton · Director
  • Michael Fawkes · Director
  • Scott Banister · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Gottbetter Capital Markets, LLC (CRD 20680) · broker-dealer EDI Financial, Inc. (CRD 15699) · New York, New YorkSold in AL, AZ, CA, CO, CT, FL, GA, IL, IN, KY, MA, MD, MS, NC, NJ, NV, NY, OH, PA, TX, WA

Remarks in the notice

  • On fees: “Cash commissions of 10% of gross proceeds plus warrants to purchase a number of shares of common stock equal to 10% of the number of shares of common stock into which notes are convertible with exercise price per share of $1.00 and a term of 5 years.”
  • On the use of proceeds: “Certain proceeds will be used by the Company for general working capital, including the payment of salaries to certain executive officers and/or directors who are listed as Related Persons herein.”

Signed by Nathan Harding, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 27, 2013. Read the notice at the SEC.

debt, optionsSEC
Dec 2011$9 MNo. 1$2 to $10 million

Ekso Bionics, Inc.: Raise no. 1, Dec 2011

Investors in this round

18 investors had bought by the notice of Jun 22, 2012: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $12 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eythor Bender · Executive Officer, Director
  • Max Scheder-Bieschin · Executive Officer
  • Nathan Harding · Executive Officer, Promoter
  • Russ Angold · Executive Officer, Promoter
  • Jack Peurach · Director
  • Marilyn Hamilton · Director
  • Michael Fawkes · Director
  • Scott Banister · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Max Scheder-Bieschin, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 22, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Ekso Bionics, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2013).

    SEC Form D · Nov 2013

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Nov 2013

That is all the official record says: Ekso Bionics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Ekso Bionics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 34 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Ekso Bionics, Inc.
NameRoleNamed in
Frank MoremandChief Operating OfficerNov 2013
Max Scheder-BieschinChief Financial OfficerNov 2013
Nathan HardingChief Executive OfficerNov 2013
Russ AngoldChief Technology OfficerNov 2013
Eythor BenderExecutive officerJun 2012
Amal MooradDirectorNov 2013
Jack PeurachDirectorNov 2013
Marilyn HamiltonDirectorNov 2013
Michael FawkesDirectorNov 2013
Nathan HardingChief Executive OfficerNov 2013
Scott BanisterDirectorNov 2013
Eythor BenderDirectorJun 2012
Amal MooradPromoterNov 2013
Russ AngoldChief Technology OfficerNov 2013
Nathan HardingPromoterJun 2012